Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa
Thrombosis and Haemostasis · 2023-11 · 123 (11) · 1034-1041
DOI: 10.1055/a-2101-7961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 10.07.2023. Verfasst von Tom W van de Berg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), University Maastricht, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Hemophilia A, Hemostatics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer HealthCare, van de Laar Stichting.
Abstract (Originalsprache)
Background
Hemophilia A (HA) is characterized by decreased or absent factor VIII (FVIII) activity. Current FVIII assays are based on clotting time and thus only provide information about the initiation of coagulation. In contrast, thrombin generation assays (TGAs) can be used to measure the full coagulation spectrum of initiation, propagation, and termination that provide information on the whole course of thrombin generation and inhibition. However, the commercially available TG kits lack sensitivity for measurements of hemophilia plasma within lower FVIII ranges, which is essential for explaining differences in bleeding phenotypes in hemophiliacs at clinically low levels of FVIII.
Aims
Optimization of the TGA for measurements of low FVIII levels in severe HA patients.
Methods
TGA measurements were performed in severe HA pooled plasma (n = 10). Investigations of several preanalytical and analytical variables of the assay were performed in a stepwise process and adjusted based on sensitivity toward intrinsic coagulation activation.
Results
TGA initiated by tissue factor (TF) alone at varying concentrations was unable to significantly differentiate between FVIII levels below 20%. In contrast, TGA activation with low concentrations of TF in presence of FXIa appeared to be highly sensitive for FVIII changes both in high and low ranges. In addition, a representative TGA curve at trough levels could only be produced using the dual TF/FXIa TGA.
Conclusion
We propose a critical optimization for the setup of the TGA for measurements in severe HA plasma. The dual TF/FXIa TGA shows increased sensitivity, especially in lower FVIII ranges, which allows for better individual characterization at baseline, prediction of interventions, and follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), University Maastricht, Maastricht, The Netherlands.
- Department of Hematology, Division of Internal Medicine, Maastricht UMC + , Maastricht, The Netherlands.
- Central Diagnostics Laboratory, Maastricht UMC + , Maastricht, The Netherlands.
ORCID-Profile: Tom W van de Berg
Förderung
- Bayer HealthCare
- van de Laar Stichting
Zitieren
APA
van de Berg, T. W., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., Henskens, Y. M. C., Thomassen, M. C. L. G. D., & Hackeng, T. M. (2023). Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa. Thrombosis and Haemostasis, 123(11), 1034-1041. https://doi.org/10.1055/a-2101-7961
Vancouver
van de Berg TW, Beckers EAM, Heubel-Moenen FCJI, Henskens YMC, Thomassen MCLGD, Hackeng TM. Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa. Thrombosis and Haemostasis. 2023;123(11):1034-1041. doi:10.1055/a-2101-7961
BibTeX
@article{vandeBerg2023,
author = {van de Berg, Tom W and Beckers, Erik A M and Heubel-Moenen, Floor C J I and Henskens, Yvonne M C and Thomassen, M Christella L G D and Hackeng, Tilman M},
title = {Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa},
journal = {Thrombosis and Haemostasis},
year = {2023},
volume = {123},
number = {11},
pages = {1034--1041},
doi = {10.1055/a-2101-7961}
}
EUVIMED